z-logo
open-access-imgOpen Access
End of therapy minimal residual disease (MRD) measurement in children with ALL does not predict relapse
Author(s) -
Tahani Hani Sarrawi,
Ismael Zayyat,
Fareed Barakat,
Maha Rezeq,
Salam Abu Jmaian,
Faris Madanat
Publication year - 2017
Publication title -
hematology/oncology and stem cell therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 22
eISSN - 1658-3876
pISSN - 2589-0646
DOI - 10.1016/j.hemonc.2017.05.033
Subject(s) - minimal residual disease , residual , medicine , statistics , oncology , mathematics , algorithm , leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom